Screener
Amneal Pharmaceuticals, Inc. AMRX Affordable Medicines — Restructuring and other charges
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Three Months Ended June 30, 2026 | Affordable Medicines (1) | Specialty | Av KARE | Corporateand Other | Total Company |
|---|---|---|---|---|---|
| Selling, general and administrative | 42,367 | 40,095 | 16,913 | 49,347 | 148,722 |
| Research and development | 33,023 | 5,994 | — | — | 39,017 |
| Intellectual property legal development expenses | 2,002 | 85 | — | — | 2,087 |
| Acquisition costs | — | — | — | 7,600 | 7,600 |
| Restructuring and other charges | — | — | — | 554 | 554 |
| Charges related to legal matters, net | 8,057 | — | — | — | 8,057 |
| Other operating income | (1,298) | — | — | — | (1,298) |
| Operating income (loss) | $123,078 | $54,856 | $9,336 | $(57,501) | $129,769 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s affordable medicines — restructuring and other charges?
- Amneal Pharmaceuticals, Inc. (AMRX) reported affordable medicines — restructuring and other charges of $0 in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s affordable medicines — restructuring and other charges changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s affordable medicines — restructuring and other charges decreased by 100.0% year-over-year, from $683K to $0.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s affordable medicines — restructuring and other charges?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s affordable medicines — restructuring and other charges has grown at a 53.5% compound annual growth rate (CAGR), from $821K to $2.97M.
- What does affordable medicines — restructuring and other charges mean?
- Represents costs associated with organizational realignments, facility closures, or workforce reductions within the Affordable Medicines segment. These charges are typically incurred to improve long-term operational efficiency and cost structure.
Ask your AI about Amneal Pharmaceuticals, Inc.'s affordable medicines — restructuring and other charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude